Login / Signup

Efficacy of topiramate as an add-on therapy in patients with refractory status epilepticus: a short systematic review.

Leonardo Christiaan WellingNícollas Nunes RabeloMarcia Harumy YoshikawaJoão Paulo Motta TellesManoel Jacobsen TeixeiraEberval Gadelha Figueiredo
Published in: Revista Brasileira de terapia intensiva (2021)
Topiramate was effective in terminating refractory status epilepticus, presented relatively low mortality and was well tolerated. Therefore, topiramate could be a good option as a third-line therapy for refractory status epilepticus, but further studies are necessary.
Keyphrases
  • systematic review
  • meta analyses
  • cardiovascular events
  • risk factors
  • randomized controlled trial
  • cardiovascular disease
  • stem cells
  • coronary artery disease
  • case control